TylvaQ500

Active Ingredients:

Each g contains Tylvalosin 500 mg.

Pharmacology

Tylvalosin tartrate is a macrolide antibiotic for animal use only. It inhibits the reproduction of bacteria by inhibiting protein synthesis. Its antibacterial spectrum is similar to that of tylosin. It has strong antibacterial activity against Staphylococcus aureus (including penicillinase resistant strain), Pneumococcus, Streptococcus, Bacillus anthracis, Erysipelothrix rhusiopathiae, Listeria monocytogenes, Clostridium putrificum, Clostridium chauvoei, et al. It also shows antibacterial activity against other antibiotic resistant Gram-positive bacteria, but almost has no antibacterial activity against Gram-negative bacteria. It has strong antibacterial activity against Mycoplasma gallisepticum and Mycoplasma synovium. Bacterial resistance to tylvalosin is not easy to produce.

Interaction with other medicinal products

Tylvalosin has antagonism to chloramphenicols and lincosamide, so not suitable for simultaneous usage.

The antibacterial effect of β-lactam antibiotics may be interfered when combined with tylvalosin. Not suitable for simultaneous use when used for treatment of the disease which need killing the bacteria rapidly.

Indication

Antibiotics. For the treatment of infection associated with Mycoplasma in swine.

Dosage and Administration

Mixed in feed: 100 - 150 g of the product per 1000 kg of feed, for 7 consecutive days.

Adverse reactions

No adverse reactions are observed at recommended dose.

Precaution

Not suitable for combined with penicillins.

Avoid contacting with the product in non-treatment animals; avoid eye and skin direct contact; personal handling the product should wear protective equipment consisting of a mask, goggles and gloves.

Keep out of reach of children.

Withdrawal time

Swine: 3 days

Storage

Store in an airtight container, protected from light, store in dry place.